BX
Baudax Bio, Inc.
BXRXQ · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $4.36K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.00x
P/E N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 452.33%
FCF margin 2,191.73%
Net margin 4,633.18%
Quality
59 /100
Average ROIC 974.83%
Asset turnover 0.13x
ROA 586.08%
Debt
70 /100
Low Current ratio 0.30x
Net debt/EBITDA -0.06x
Debt/Equity N/A
Stability
14 /100
Unstable Beta 9.17x
Profitable years 0
EPS volatility 55.97%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BXRXQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gerri Henwood
Employees
9
Headquarters
Malvern
Upcoming events
11 NOV
Earnings
Upcoming earnings report